4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Apogee Therapeutics, Inc. (APGE) operates in the Biotechnology industry and is headquartered in Waltham, United States with about 261 employees. Its market capitalization is roughly $10 billion. In the fiscal year ended 2025-12-31, APGE reported $0M in revenue and ($256M) in net income.
Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($286M) | ($217M) | ($93M) | ($31M) |
| Net Income | ($256M) | ($182M) | ($84M) | ($40M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($83M) | ($78M) | ($71M) | ($73M) | ($63M) |
| Net Income | ($74M) | ($69M) | ($65M) | ($66M) | ($55M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $937M | $754M | $401M | $152M |
| Total Liabilities | $33M | $37M | $22M | $10M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive APGE viewer.
About TickerBase · Data methodology & sources